ADAGE Capital Partners Gp, LLC, 10% Owner at PUMA BIOTECHNOLOGY, INC. (PBYI), sold 507,128 shares at $82.41 ($44.5M) on 2017-06-01, disclosed to the SEC on 2017-06-05.
Open-market sale of $44.5M PBYI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $82.41 | 164,325 | $13.5M | 30.4% |
| 2 | $83.55 | 5,200 | $434K | 1.0% |
| 3 | $83.06 | 30,475 | $2.5M | 5.7% |
| 4 | $85.32 | 1,100 | $94K | 0.2% |
| 5 | $88.12 | 63,227 | $5.6M | 12.5% |
| 6 | $90.21 | 152,762 |
| $13.8M |
| 30.9% |
| 7 | $91.31 | 23,272 | $2.1M | 4.8% |
| 8 | $92.00 | 3,083 | $284K | 0.6% |
| 9 | $96.61 | 52,016 | $5.0M | 11.3% |
| 10 | $99.08 | 11,668 | $1.2M | 2.6% |
| Total | $87.84 avg | 507,128 | $44.5M | 100% |
| Filing → |
| GCMG | BUY | 2021-07-13 | $4.3M | — | Filing → |
| GCMG | SELL | 2021-07-13 | $8.6M | — | Filing → |
| GCMG | SELL | 2021-07-13 | $1.5M | — | Filing → |